StemCentRx

Stemcentrx, Inc. was founded in 2008, combining cutting-edge research with GMP manufacturing capabilities. This enables us to rapidly progress from target discovery in the lab to patient treatment in clinical trials. We are researching many of the largest and most lethal cancers through our proprietary platforms, which identify cancer stem cells, discover new targets, and design and manufacture antibodies as well as antibody-drug conjugates. Our mission is to develop therapies that can cure cancer and significantly improve survival rates for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and driven team dedicated to this mission.